Literature DB >> 14506399

Mean corpuscular volume and the aldehyde dehydrogenase-2 genotype in male Japanese workers.

Masako Yokoyama1, Akira Yokoyama, Tetsuji Yokoyama, Genichi Hamana, Kazuo Funazu, Shuji Kondo, Takeshi Yamashita, Haruko Yoshimizu, Haruo Nakamura.   

Abstract

BACKGROUND: Increased mean corpuscular volume (MCV) is common in alcohol abusers and alcoholics. MCV is higher in Japanese heavy drinkers with inactive aldehyde dehydrogenase-2 (ALDH2) encoded by ALDH2*1/2*2 than among those with active ALDH2 encoded by ALDH2*1/2*1. Inactive ALDH2 dramatically increases blood acetaldehyde levels after alcohol intake. Because moderate and heavy drinkers with ALDH2*1/2*2 have very high risks for esophageal cancer, MCV might serve as an indicator of these high-risk drinkers.
METHODS: In this investigation of the association of red cell values with the ALDH2 genotype and possible confounding factors, the drinking, smoking, and dietary habits reported on a structured questionnaire by 163 Japanese working men were subjected to multivariate analyses.
RESULTS: Aging, lower body mass index (BMI), more alcohol consumption, and more smoking were positively associated with increased MCV. Among moderate to heavy drinkers (>or=9 units/week; 1 unit = 22 g of ethanol), both MCV and mean corpuscular hemoglobin were higher and the red cell count was lower in those with ADLH2*1/2*2 than in those with ALDH2*1/2*1. Multiple linear regression analysis after adjustment for age, BMI, and smoking revealed that a positive relationship between the amount of drinking and MCV but inverse relationships for drinking and red cell count, as well as hemoglobin and hematocrit values, were significantly stronger for men with ALDH2*1/2*2 than for those with ALDH2*1/2*1, demonstrating a gene-environment interaction. Drinking accounted for 19.9% of interindividual MCV variance among men with ALDH2*1/*2*2 but for only 1.3% of variance among those with ALDH2*1/2*1. Age, BMI, drinking, and smoking accounted for 52.1 and 34.7% of the variation among those with ALDH2*1/2*2 and ALDH2*1/2*1, respectively. Macrocytosis (MCV >or=100.0 fl) was observed in 18 subjects (11.0%), and use of macrocytosis as a biomarker of moderate to heavy drinkers with ALDH2*1/2*2 had a sensitivity of 54.5% (6 of 11) and a specificity of 92.1% (140 of 152).
CONCLUSIONS: Alcohol-related red cell value changes associated with inactive ALDH2 in Japanese men suggest the importance of acetaldehyde's role in increasing MCV and the potential for using MCV as a marker for high-risk drinkers for esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506399     DOI: 10.1097/01.ALC.0000085589.47243.8D

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  7 in total

1.  Association between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma.

Authors:  Chikatoshi Katada; Tetsuji Yokoyama; Tomonori Yano; Ichiro Oda; Yuichi Shimizu; Hisashi Doyama; Tomoyuki Koike; Kohei Takizawa; Motohiro Hirao; Hiroyuki Okada; Takako Yoshii; Yutaro Kubota; Takenori Yamanouchi; Takashi Tsuda; Tai Omori; Nozomu Kobayashi; Haruhisa Suzuki; Satoshi Tanabe; Keisuke Hori; Norisuke Nakayama; Hirofumi Kawakubo; Naomi Kakushima; Yasumasa Matsuo; Hideki Ishikawa; Akira Yokoyama; Manabu Muto
Journal:  Esophagus       Date:  2019-07-08       Impact factor: 4.230

2.  Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.

Authors:  Yuki Matsumura; Na Li; Hanan Alwaseem; Odelya E Pagovich; Ronald G Crystal; Matthew B Greenblatt; Katie M Stiles
Journal:  Hum Gene Ther       Date:  2020-01-28       Impact factor: 5.695

3.  Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma.

Authors:  Yu-Zhen Zheng; Shu-Qin Dai; Wei Li; Xun Cao; Yong Li; Lan-Jun Zhang; Jian-Hua Fu; Jun-Ye Wang
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

Review 4.  Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency.

Authors:  Rachel A Montel; Carlos Munoz-Zuluaga; Katie M Stiles; Ronald G Crystal
Journal:  Cancer Gene Ther       Date:  2021-11-19       Impact factor: 5.854

5.  Mean Corpuscular Volume as a Prognostic Factor for Patients With Habitual Alcohol or Tobacco Use After Esophagectomy.

Authors:  Shu-Jie Huang; Peng-Fei Zhan; Shao-Bin Chen
Journal:  Front Oncol       Date:  2021-11-16       Impact factor: 6.244

6.  Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males.

Authors:  Yasuko Nezu; Noriaki Manabe; Yoshioki Yoda; Ken Haruma
Journal:  United European Gastroenterol J       Date:  2022-08-17       Impact factor: 6.866

7.  Recovery from anemia and leukocytopenia after abstinence in Japanese alcoholic men and their genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2.

Authors:  Akira Yokoyama; Philip J Brooks; Tetsuji Yokoyama; Takeshi Mizukami; Shunsuke Shiba; Nobuhiro Nakamoto; Katsuya Maruyama
Journal:  Jpn J Clin Oncol       Date:  2017-04-01       Impact factor: 3.019

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.